Leerink Partnrs Has Bullish Outlook for WBA Q2 Earnings

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) – Stock analysts at Leerink Partnrs upped their Q2 2025 earnings estimates for Walgreens Boots Alliance in a research note issued on Tuesday, December 17th. Leerink Partnrs analyst M. Cherny now expects that the pharmacy operator will post earnings per share of $0.49 for the quarter, up from their prior forecast of $0.47. The consensus estimate for Walgreens Boots Alliance’s current full-year earnings is $1.53 per share.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. During the same period in the previous year, the company earned $0.67 earnings per share. The company’s quarterly revenue was up 5.9% on a year-over-year basis.

Other equities research analysts have also recently issued research reports about the stock. Barclays boosted their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 16th. UBS Group boosted their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, October 17th. Royal Bank of Canada lowered their price objective on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a research note on Wednesday, December 4th. JPMorgan Chase & Co. reduced their target price on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Finally, Jefferies Financial Group dropped their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $12.58.

Walgreens Boots Alliance Trading Down 1.3 %

WBA traded down $0.13 during trading on Thursday, reaching $9.57. 2,452,863 shares of the stock traded hands, compared to its average volume of 18,143,385. The stock has a market capitalization of $8.27 billion, a PE ratio of -0.96, a P/E/G ratio of 1.36 and a beta of 0.66. Walgreens Boots Alliance has a 12 month low of $8.08 and a 12 month high of $27.05. The stock’s 50-day moving average is $9.33 and its 200 day moving average is $10.60. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.

Institutional Investors Weigh In On Walgreens Boots Alliance

A number of institutional investors have recently modified their holdings of the business. B. Riley Wealth Advisors Inc. raised its position in Walgreens Boots Alliance by 145.0% during the third quarter. B. Riley Wealth Advisors Inc. now owns 51,832 shares of the pharmacy operator’s stock valued at $456,000 after buying an additional 30,675 shares during the period. Franklin Resources Inc. boosted its stake in shares of Walgreens Boots Alliance by 54.4% in the 3rd quarter. Franklin Resources Inc. now owns 321,425 shares of the pharmacy operator’s stock valued at $2,893,000 after purchasing an additional 113,242 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in Walgreens Boots Alliance during the 3rd quarter valued at $92,000. Sanctuary Advisors LLC raised its position in Walgreens Boots Alliance by 79.0% in the 3rd quarter. Sanctuary Advisors LLC now owns 46,333 shares of the pharmacy operator’s stock valued at $401,000 after purchasing an additional 20,450 shares during the last quarter. Finally, Wealthquest Corp bought a new stake in shares of Walgreens Boots Alliance during the third quarter worth $130,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Stockholders of record on Monday, November 18th were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 10.45%. Walgreens Boots Alliance’s dividend payout ratio is presently -9.99%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.